Gujarat FDCA notifies 145 MD officers for audits, 30 state licensing officers for grant of medical device licenses

Shardul Nautiyal, Mumbai

In order to implement the new Medical Device (MD) Rules, the Gujarat Food and Drug Control Administration (FDCA) has notified 145 MD officers to inspect Class A and Class B medical device

CDSCO seizes illegal stock of oxytocin injections worth Rs. 95 lakh from 2 drug companies in Bihar

Laxmi Yadav, Mumbai

Stepping up efforts to check illegal manufacturing and import of oxytocin in the country, the Central Drugs Standard Control Organisation (CDSCO) along with Bihar drugs control administration has raided 35 manufacturing units at Gaya and Bodh Gaya

Govt to rope in project consultant to implement new pharma cluster development scheme on PPP basis

Arun Sreenivasan, NEW DELHI

The Department of Pharmaceuticals (DoP) will rope in a third-party project management consultant (PMC) to execute the proposed pharmaceutical cluster development programme to be implemented on a public-private partnership (PPP) format.

Asia's first govt rapid microbiological testing lab to become operational soon in Gujarat

Shardul Nautiyal, Mumbai

Equipped to handle and test multiple samples in two hours time, Gujarat Food and Drug Control Administration (FDCA) is all set to create a benchmark in terms of testing and analysis of contamination of pharmaceutical products

APDCA asks customers to register complaints if pharmacies overcharge drug prices set by NPPA

A Raju, Hyderabad

The Andhra Pradesh Drug Control Administration (APDCA) authorities, with an aim to create awareness among the general public about low prices of generic drugs fixed by the National Pharmaceutical Pricing Authority’s (NPPA)

DoP rejects Sun Pharma’s petition to review ceiling price of Amphotericin B Liposomal 50mg injection

Arun Sreenivasan, New Delhi

The Department of Pharmaceuticals (DoP) has turned down a review petition filed by Sun Pharma Laboratories against the ceiling price fixed by the National Pharmaceuticals Pricing Authority (NPPA) for its Amphotericin B Liposomal 50mg injection.

Gujarat FDCA approves layout designs of 150 new mfg units including major foreign players during last one year

Shardul Nautiyal, Mumbai

The Gujarat Food and Drug Control Administration (FDCA) has approved layout designs of 150 pharmaceutical companies including the major ones being of American medical technology provider Abbott, Israel

DTAB panel concludes hearings on FDC ban review; Aidan remains optimistic about petition outcome

Arun Sreenivasan, New Delhi

A Drugs Technical Advisory Board (DTAB) sub-committee reviewing the ban on 349 fixed dose combination (FDC) drugs has completed hearings of petitioners and appellants and is expected to submit its final report

Maha FDA to start risk based inspections of Sch M units towards meeting global compliance levels

Shardul Nautiyal, Mumbai

The Maharashtra FDA will soon start risk based inspections to check the compliance levels for good manufacturing practices (GMPs) following responses of self-audit from around 800 manufacturers in the state.

Centre-state initiative to set up common facility centres at API parks; Rs 200 crore earmarked for 2018-20

Arun Sreenivasan, New Delhi

Facing criticism over its failure to create a favourable environment for the domestic bulk drug industry while foreign countries queue up with incentive-laced offers to woo Indian firms, the government has come up


Enquiry Form